Dow Up2.00% Nasdaq Up1.66%

Acura Pharmaceuticals, Inc. (ACUR)

-NasdaqCM
2.17 Up 0.01(0.46%) Feb 12, 3:36PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 210   341   5,357   529  
Cost of Revenue132  98  324  39  
Gross Profit 78   243   5,033   490  
Operating Expenses
Research Development432  511  964  908  
Selling General and Administrative2,024  2,083  2,297  2,037  
Non Recurring27  47  260   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,405) (2,398) 1,512   (2,455)
Income from Continuing Operations
Total Other Income/Expenses Net39  36  35  64  
Earnings Before Interest And Taxes(2,366)(2,362)1,547  (2,391)
Interest Expense283  301  308  305  
Income Before Tax(2,649)(2,663)1,239  (2,696)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,649)(2,663)1,239  (2,696)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,649) (2,663) 1,239   (2,696)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,649) (2,663) 1,239   (2,696)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.